Basic Information
Contenta was founded during the COVID-19 pandemic to develop and produce a new generation of edible vaccines. Contenta's technology can produce vaccines targeting different viruses and gastrointestinal cancers. The Contenta team has long-term experience in microbiome research, genetics, diagnostic marker identification, and drug development.